Stifel Financial’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-14,983
Closed -$1.53M 3437
2023
Q2
$1.53M Buy
14,983
+124
+0.8% +$12.6K ﹤0.01% 1801
2023
Q1
$1.35M Buy
14,859
+4,103
+38% +$373K ﹤0.01% 1825
2022
Q4
$409K Buy
10,756
+587
+6% +$22.3K ﹤0.01% 2589
2022
Q3
$256K Sell
10,169
-268
-3% -$6.75K ﹤0.01% 2822
2022
Q2
$317K Sell
10,437
-147
-1% -$4.47K ﹤0.01% 2722
2022
Q1
$347K Buy
10,584
+994
+10% +$32.6K ﹤0.01% 2788
2021
Q4
$253K Sell
9,590
-34,694
-78% -$915K ﹤0.01% 3010
2021
Q3
$4.46M Sell
44,284
-475
-1% -$47.8K 0.01% 1081
2021
Q2
$6.33M Buy
44,759
+2,684
+6% +$380K 0.01% 896
2021
Q1
$4.2M Buy
42,075
+3,152
+8% +$314K 0.01% 1052
2020
Q4
$4.81M Buy
38,923
+8,402
+28% +$1.04M 0.01% 898
2020
Q3
$2.97M Sell
30,521
-5,449
-15% -$531K 0.01% 1014
2020
Q2
$5.61M Buy
35,970
+346
+1% +$54K 0.01% 688
2020
Q1
$5.13M Buy
35,624
+5,158
+17% +$743K 0.01% 653
2019
Q4
$6.21M Sell
30,466
-606
-2% -$124K 0.01% 795
2019
Q3
$2.49M Buy
31,072
+519
+2% +$41.6K 0.01% 1178
2019
Q2
$2.88M Sell
30,553
-1,432
-4% -$135K 0.01% 1117
2019
Q1
$2.75M Buy
31,985
+3,356
+12% +$288K 0.01% 1079
2018
Q4
$1.61M Sell
28,629
-2,649
-8% -$149K 0.01% 1265
2018
Q3
$2.55M Buy
31,278
+2,492
+9% +$203K 0.01% 1135
2018
Q2
$997K Buy
28,786
+616
+2% +$21.3K ﹤0.01% 1617
2018
Q1
$575K Buy
28,170
+20,069
+248% +$410K ﹤0.01% 1890
2017
Q4
$229K Buy
+8,101
New +$229K ﹤0.01% 2363